Skip to main contentSkip to navigation
Ovarian Cancer Research Alliance
Research Exchange
Donate

Investigator

Yuxi Wang

Sichuan University West China Hospital

YWYuxi Wang
Papers(2)
Discovery of Novel 4,…Design, Synthesis, an…
Collaborators(4)
Jifa ZhangLiang OuyangWeimin LiYang He
Institutions(2)
Sichuan UniversityState Key Laboratory …

Papers

Discovery of Novel 4,5-Dihydropyrrolo[3,4-c]pyrazol-6(2H)-one-Based Tubulin Inhibitors Targeting Colchicine Binding Site with Potent Anti-Ovarian Cancer Activity

To address the toxicity of current microtubule inhibitors, we employed the GeminiMol deep learning model to screen the Zinc20 database, identifying a novel 4,5-dihydropyrrolo[3,4-

Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site

Herein, a series of quinazoline and heterocyclic fused pyrimidine analogues were designed and synthesized based on the X-ray co-crystal structure of lead compound

2Papers
4Collaborators
Cell Line, TumorNeoplasmsApoptosisLung NeoplasmsDrug Resistance, NeoplasmXenograft Model Antitumor AssaysCarcinoma, Non-Small-Cell Lung

Positions

2016–

Researcher

Sichuan University West China Hospital

Links & IDs
0000-0002-4056-5829
Ovarian Cancer Research Alliance

A global leader in the fight against gynecologic cancer

LIVING LAB
Join the Living LabOur TeamGovernance & EthicsSocial Media Toolkit
DISCOVERY LAB
Discovery LabHow It WorksUpcoming WebinarsContribute Data
ABOUT
About OCRAGet InvolvedMake a DonationContact Us

© 2025 Ovarian Cancer Research Alliance, Inc.

PrivacyTermsAccessibility